Yooyoung to introduce Nippon Shinyaku’s NS-126
Published: 2008-06-11 06:22:00
Updated: 2008-06-11 06:22:00
Yooyoung Pharm and Nippon Shinyaku Co. have recently announced an exclusive license agreement, under which Yooyoung will acquire exclusive rights in Korea to develop and commercialize NS-126, an agent for allergic rhinitis and asthma.
NS-126 is a dry powder form containing a novel steroid comp...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
